Pharmaceutical Prices in the 21st Century

The book is an essential, comprehensive text onglobal drug pricing and covers a range of pharmaceutical pricing issues. It has twenty-two chapters in total;nineteenof which are case studieson an array of high, middle, and low income countries. The final three chaptersdiscussvalue-based pricing, inno...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Babar, Zaheer-Ud-Din (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Adis, 2015.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03346nam a22004095i 4500
001 978-3-319-12169-7
003 DE-He213
005 20151204144830.0
007 cr nn 008mamaa
008 141205s2015 gw | s |||| 0|eng d
020 |a 9783319121697  |9 978-3-319-12169-7 
024 7 |a 10.1007/978-3-319-12169-7  |2 doi 
040 |d GrThAP 
050 4 |a RA410-410.9 
072 7 |a KCQ  |2 bicssc 
072 7 |a BUS069000  |2 bisacsh 
082 0 4 |a 338.473621  |2 23 
245 1 0 |a Pharmaceutical Prices in the 21st Century  |h [electronic resource] /  |c edited by Zaheer-Ud-Din Babar. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Adis,  |c 2015. 
300 |a X, 411 p. 37 illus., 34 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Introduction -- Reference pricing strategies -- Differential pricing -- Prices of vaccines. 
520 |a The book is an essential, comprehensive text onglobal drug pricing and covers a range of pharmaceutical pricing issues. It has twenty-two chapters in total;nineteenof which are case studieson an array of high, middle, and low income countries. The final three chaptersdiscussvalue-based pricing, innovation, prices and the pharmaceutical industry and the link betweenpharmaceutical policy and pricing. As the pharmaceutical market continues to expand, a number of pharmaceutical pricing strategies have been employed to control drug expenditures. The book explores this phenomenon further and willserve a valuable resource for policy makers, funders, social insurance institutions and drug companies.  About the author Zaheer-Ud-Din Babar, PhD is the Head of Pharmacy Practice at the School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a PhD in pharmaceutical policy, Dr Babar is a recipient of the prestigious “Research Excellence Award” from the University of Auckland. His research program covers areas related to pharmaceutical policy and practice, encompassing access to and affordability of medicines, issues related to medicine pricing and pharmacoeconomics. Dr Babar has delivered invited lectures at Boston University School of Public Health, Harvard Medical School, the Austrian Health Institute and the Universities of Reading and Kingston. He has also acted as a consultant for the World Health Organization, Health Action International, the International Union against Tuberculosis and Lung Disease, the International Pharmaceutical Federation (FIP) and the Pharmaceutical Management Agency of New Zealand in the area of medicines pricing and policies. Dr Babar is the Editor in Chief of the Journal of Pharmaceutical Policy and Practice, www.joppp.org and can be reached at z.babar@auckland.ac.nz. 
650 0 |a Health economics. 
650 0 |a Medical economics. 
650 1 4 |a Economics. 
650 2 4 |a Health Economics. 
700 1 |a Babar, Zaheer-Ud-Din.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319121680 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-12169-7  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBE 
950 |a Business and Economics (Springer-11643)